Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

ENOV Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Enovis CorporationNYSE: ENOV

Accounts Payables · Q1 FY2026 · quarter ended Apr 2026

Accounts payables growth accelerates

Q1 FY2026 accounts payables of $26.89M rose 541.8% year over year, ahead of the -27.9% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -54.2% a year.

Context

  • Accounts payables amounted to 0.1% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +541.8% holds above the trailing-twelve-month pace of -27.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
$26.89M+334.2% QoQ
Last fiscal yearDec 2025
-$1.14M-108.1% YoY
LTMApr 2026
$21.56M-27.9% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+541.8%——
1 year-108.1%——
3-year CAGR-54.2%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(1.14M) USD
Year-over-year change
-108.1%

Accounts Payables vs competitors

How ENOV compares with its peers on the latest reported figures

  • ENOV's LTM Apr 2026 accounts payables of $21.56M is the 4th largest of the 16 companies compared; the peer median is $2.63M.
  • Its year-over-year change of -27.9% is the 13th highest of 15, against a peer median of +179.3%.
  • Accounts payables amounts to 0.9% of revenue for ENOV, versus a peer median of 0.7%.
ENOV Competitors Peer median
Accounts Payables for ENOV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FELEFranklin Electric Co., Inc.LTM Sep 2026$36.05M +276.3%+1.3%1.6%
ITTITT Inc.LTM Jul 2026$33.1M +310.8%—0.7%
IEXIDEX CorporationLTM Jun 2026$25.1M +217.7%-4.8%0.7%
ENOVEnovis CorporationLTM Apr 2026$21.56M -27.9%-54.2%0.9%
MIDDThe Middleby CorporationLTM Jul 2026$20.24M +219.7%—0.6%
WTSWatts Water Technologies, Inc.LTM Jun 2026$19.1M -40.9%—0.7%
HLIOHelios Technologies, Inc.LTM Jul 2026$14.7M +388.2%—1.6%
NPOEnPro Industries, Inc.LTM Jun 2026$12M +103.4%—1.0%
KAIKadant Inc.LTM Jul 2026$6.67M +66.1%—0.6%
HURCHurco Companies, Inc.LTM Apr 2026$2.63M +160.9%—1.4%
EPACEnerpac Tool Group Corp.LTM Feb 2026$2.56M +42.5%—0.4%
GRCThe Gorman-Rupp CompanyLTM Jun 2026$2.16M +197.7%—0.3%
LXFRLuxfer Holdings PLCLTM Mar 2026$2.04M +138.4%—0.5%
GHMGraham CorporationLTM Mar 2026$794K -122.7%—0.3%
OFLXOmega Flex, Inc.LTM Mar 2026$774K +215.7%-47.7%0.8%
DCIDonaldson Company, Inc.LTM Jul 2026$0 ——0.0%
Peer median (excluding ENOV) $2.63M+179.3%-4.8%0.7%

Competitors are the stored peer set for ENOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income76.28M(11.76M)(33.26M)(824.82M)(1.18B)
Depreciation & Amortization262.92M219.71M217.1M284.8M294.38M
Deferred Income Tax(22.19M)6.32M(27.41M)(10.02M)(2.23M)
Stock-Based Compensation35.35M38.96M34.07M29.66M32.92M
Change in Working Capital(17.1M)(220.49M)(27.27M)(13.93M)15.47M
Accounts Receivables(110.99M)(45.19M)(16.32M)(57.05M)(10.75M)
Inventory(129.97M)(118.79M)(24.74M)39.07M(11.98M)
Accounts Payables178.47M(11.84M)(6.64M)13.98M(1.14M)
Other Working Capital45.38M(44.67M)20.42M(9.93M)39.34M
Other Non-Cash Items20.84M(88.59M)(28.24M)647.81M1.06B
Operating Cash Flow356.1M(55.86M)134.99M113.5M217.29M
Capital Expenditures(104.24M)(105.45M)(122.22M)(180.71M)(197.38M)
Acquisitions (Net)(223.27M)(73.68M)(152.82M)(769.91M)16.4M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities7.03M2.75M32.57M(4.85M)1.6M
Investing Cash Flow(320.48M)(176.39M)(242.47M)(955.47M)(179.37M)
Debt Repayment(150.41M)(1.59B)217.2M859.23M(43.6M)
Common Stock Issued745.18M5.81M1.78M1.87M1.32M
Common Stock Repurchased000(4.77M)0
Dividends Paid00000
Other Financing Activities(9.87M)1.12B(91.17M)(9.51M)(10.12M)
Financing Cash Flow584.91M(465.13M)127.8M846.82M(52.4M)
Effect of Forex Changes(2.23M)2.3M219K(1.52M)2.7M
Net Change in Cash618.3M(695.08M)20.54M3.34M(11.78M)
Free Cash Flow251.86M(161.31M)12.77M(67.21M)19.92M

Enovis Corporation

NYSE:ENOV

Intrinsic Alpha fair value

Locked

Current Price

$27.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.